Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin Effects on Buprenorphine Pharmacokinetics and Pharmacodynamics
NCT01854489Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in pain, opioid use disorder (OUD), sponsored by Turku University Hospital. Started Apr 2013; status: completed.
02
Drugs
buprenorphine
03
Conditions
painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01854489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854489.